Merck & Co. Inc.
MRK,
-1.60%
and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) with the Food and Drug Administration for molnupiravir, their oral antiviral medicine for the treatment…

Click here to view the original article.